Comparison of the muscarinic-cholinergic and lysophosphatidate inhibition of fibroblast adenylate cyclase demonstrating desensitization to the cholinergic stimulus.
D000067956:Adenylyl Cyclase Inhibitors; D000527:Alprostadil; D001285:Atropine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D005347:Fibroblasts / Q000187:drug effects / Q000201:enzymology; D006207:Half-Life; D006801:Humans; D008246:Lysophospholipids; D010712:Phosphatidic Acids / Q000494:pharmacology*; D011458:Prostaglandins E / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*
D000067956:Adenylyl Cyclase Inhibitors; D008246:Lysophospholipids; D010712:Phosphatidic Acids; D011458:Prostaglandins E; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D001285:Atropine; D002217:Carbachol; D000242:Cyclic AMP; D000527:Alprostadil; C032881:lysophosphatidic acid; D004837:Epinephrine